Dallah Healthcare Holding Company (4004)

Currency in SAR
134.00
-2.40(-1.76%)
Closed·
4004 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
4004 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
133.50135.40
52 wk Range
109.00169.40
Key Statistics
Bid/Ask
133.70 / 134.00
Prev. Close
136.4
Open
135.2
Day's Range
133.5-135.4
52 wk Range
109-169.4
Volume
40.77K
Average Volume (3m)
73.59K
1-Year Change
-15.59%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4004 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
139.50
Upside
+4.10%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Providers & Services industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Dallah Healthcare Holding Company Company Profile

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia.

Compare 4004 to Peers and Sector

Metrics to compare
4004
Peers
Sector
Relationship
P/E Ratio
27.2x22.0x−0.5x
PEG Ratio
0.840.580.00
Price/Book
3.4x3.0x2.6x
Price / LTM Sales
4.2x3.7x3.3x
Upside (Analyst Target)
6.0%29.4%43.3%
Fair Value Upside
Unlock28.2%6.9%Unlock

Analyst Ratings

2 Buy
6 Hold
3 Sell
Ratings:
11 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 139.50
(+4.10% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.20%
Dividend Yield
1.47%
Industry Median 1.81%
Annualised payout
2.00
Paid quarterly
5-Years Growth
+8.45%
Growth Streak

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
1.23 / 1.13
Revenue / Forecast
1.06B / 896.21M
EPS Revisions
Last 90 days

4004 Income Statement

People Also Watch

42.04
7010
-1.36%
57.00
2010
-0.61%
12.84
4190
-1.00%
25.60
1150
-0.70%

FAQ

What Stock Exchange Does Dallah Health Trade On?

Dallah Health is listed and trades on the Saudi Arabia Stock Exchange stock exchange.

What Is the Stock Symbol for Dallah Health?

The stock symbol for Dallah Health is "4004."

What Is the Dallah Health Market Cap?

As of today, Dallah Health market cap is 13.53B.

What Is Dallah Health's Earnings Per Share (TTM)?

The Dallah Health EPS (TTM) is 5.20.

When Is the Next Dallah Health Earnings Date?

Dallah Health will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is 4004 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Dallah Health Stock Split?

Dallah Health has split 3 times.

How Many Employees Does Dallah Health Have?

Dallah Health has 0 employees.

What is the current trading status of Dallah Health (4004)?

As of 11 Aug 2025, Dallah Health (4004) is trading at a price of 134.00, with a previous close of 136.40. The stock has fluctuated within a day range of 133.50 to 135.40, while its 52-week range spans from 109.00 to 169.40.

What Is Dallah Health (4004) Price Target According to Analysts?

The average 12-month price target for Dallah Health is SAR139.5, with a high estimate of SAR183 and a low estimate of SAR92.6. 2 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Neutral. The stock has an +4.10% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.